<DOC>
	<DOCNO>NCT00152932</DOCNO>
	<brief_summary>Impaired ocular blood flow important risk factor pathogenesis primary open angle glaucoma ( POAG ) . A study suggest topical dorzolamide 2 % may increase optic nerve perfusion . The objective study learn effect dorzolamide retinal optic nerve blood flow glaucoma patient . The present study prospective , randomize , double-masked , crossover design study newly diagnose already treated patient early glaucoma . The investigator check ocular blood flow parameter use Canon Laser Blood Flowmeter ( CLBF ) , use evaluate retinal arteriole blood flow , Heidelberg retinal flowmeter ( HRF ) , measure blood flow capillary bed retina optic nerve head . Any demonstrate improvement retinal optic nerve blood flow dorzolamide , mean drug may protect ischaemic nerve retinal damage . Any documented improvement flow could lead major change management glaucoma patient well retinal ischemic disease diabetic retinopathy central retinal vein occlusion .</brief_summary>
	<brief_title>Ocular Blood Flow Early Glaucoma Patients Before After Treatment With Dorzolamide</brief_title>
	<detailed_description>High intraocular pressure ( IOP ) major risk factor glaucoma . Lowering intraocular pressure still accept form treatment glaucoma . Over past decade , epidemiological experimental evidence suggest impaired ocular blood flow important risk factor important role pathogenesis primary open angle glaucoma ( POAG ) . Several study suggest ischemia-promoting vascular factor may contribute glaucomatous damage include vasospasm , impair ocular perfusion pressure general vascular disorder low blood pressure , especially dip blood pressure night . Different technique employ assess vascular dysfunction eye . As methodology ocular blood flow assessment complex differs various aspect ( e.g . target tissue physiological parameter ) , comparative study require order enhance interpretation measurement . Our laboratory state art equipment ass ocular blood flow . One study do u suggest one drop Dorzolamide 2 % improve retinal blood flow normal eye . In present study plan extend study 2 week treatment patient POAG . Dorzolamide hydrochloride 2 % topical carbonic anhydrase inhibitor reduce intraocular pressure ( IOP ) decrease production aqueous humour . Pharmacological study volunteer glaucoma patient , use Color Doppler Imaging ( measure retrobulbar blood flow ) Scanning laser Ophthalmoscopy ( measure arteriovenous passage time ) , indicate topically apply Dorzolamide may increase perfusion optic nerve peripapillary retina .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<criteria>1 . Males females 2080 year age . 2 . Presence typical early glaucomatous optic disc change ( cup/disc ratio ≤ 0.75 ) and/or early glaucomatous visual field defect ( mean deviation le 5dB outside 10° fixation ) study eye baseline visit . 3 . Best correct visual acuity least 20/40 . 4 . Signed informed consent subject 5 . The subject able understand instruction perform HRF CLBF test well willing able comply study schedule treatment . 1 . Pregnant woman nurse mother . 2 . Any active ocular disease ( ocular infection , Uveitis , etc . ) 3 . Known allergy sensitivity study medication . 4 . Functionally significant visual field loss ( mean deviation great 5dB ) cup/disc ratio great 0.75 evidence progressive visual field loss within last 6 month . 5 . Required chronic use ocular systemic hypotensive medication study , study medication ( e.g . betablockers , Cachannel blocker ) 6 . Vascular occlusive disease affect ocular circulation : diabetic retinopathy , central retinal vein occlusion , central retinal artery occlusion , nonarteritic ischemic optic neuropathy . 7 . Previous intraocular surgery ocular trauma . 8 . Any past history serious systemic condition affect cerebral circulation include : hypertension , diabetes , cerebral vascular accident ( CVA ) , coronary artery bypass graft ( CABG ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Intraocular pressure</keyword>
	<keyword>Ocular blood flow</keyword>
	<keyword>Laser-Doppler Flowmetry</keyword>
</DOC>